tiprankstipranks
Trending News
More News >
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H (HK:1558)
:1558
Hong Kong Market

YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H (1558) Financial Statements

Compare
0 Followers

YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H Financial Overview

YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H's market cap is currently HK$11.49B. The company's EPS TTM is HK$0.594; its P/E ratio is 24.07; YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H is scheduled to report earnings on March 21, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 3.72B¥ 6.29B¥ 3.74B¥ 913.79M¥ 2.35B
Gross Profit¥ 2.79B¥ 4.99B¥ 2.85B¥ 483.70M¥ 2.00B
Operating Income¥ 674.47M¥ 2.35B¥ 322.72M¥ -458.11M¥ 833.69M
EBITDA¥ 1.05B¥ 2.75B¥ 691.48M¥ -206.55M¥ 950.24M
Net Income¥ 482.71M¥ 1.99B¥ 76.60M¥ -587.65M¥ 839.46M
Balance Sheet
Cash & Short-Term Investments¥ 1.41B¥ 1.69B¥ 1.21B¥ 1.13B¥ 2.04B
Total Assets¥ 12.43B¥ 12.74B¥ 11.89B¥ 10.54B¥ 9.56B
Total Debt¥ 2.23B¥ 2.61B¥ 3.82B¥ 3.19B¥ 3.01B
Net Debt¥ 831.06M¥ 934.91M¥ 2.90B¥ 2.06B¥ 965.69M
Total Liabilities¥ 3.92B¥ 4.81B¥ 5.82B¥ 4.52B¥ 4.46B
Stockholders' Equity¥ 8.51B¥ 7.94B¥ 5.88B¥ 5.81B¥ 4.89B
Cash Flow
Free Cash Flow¥ 0.00¥ 1.08B¥ 1.13B¥ -1.02B¥ 305.33M
Operating Cash Flow¥ 0.00¥ 1.67B¥ 1.70B¥ -662.51M¥ 1.30B
Investing Cash Flow¥ 0.00¥ 554.57M¥ -1.12B¥ -439.11M¥ -2.09B
Financing Cash Flow¥ 0.00¥ -1.48B¥ -787.03M¥ 187.48M¥ 64.63M
Currency in CNY

YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H Earnings and Revenue History

YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H Debt to Assets

YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H Cash Flow

YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis